TY  - JOUR
AU  - Reifs, Carmen María Alcántara
AU  - Salido-Vallejo, Rafael
AU  - Garnacho-Saucedo, Gloria María
AU  - Corte-Sánchez, Sofía De la
AU  - González-Menchen, Alberto
AU  - García-Nieto, Antonio Vélez
PY  - 2016
DO  - 10.1590/abd1806-4841.20164322
UR  - http://hdl.handle.net/10668/10596
T2  - Anais brasileiros de dermatologia
AB  - Sézary syndrome is a primary cutaneous T-cell lymphoma characterized by the triad of erythroderma, lymphadenopathy and circulating atypical cells. The emergence of new molecular targets has enabled the development of drugs such as alemtuzumab, an...
LA  - en
KW  - Aged
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal, Humanized
KW  - Antigens, Differentiation, T-Lymphocyte
KW  - Antineoplastic Agents
KW  - Blood Cell Count
KW  - Humans
KW  - Male
KW  - Sezary Syndrome
KW  - Skin Neoplasms
KW  - Treatment Outcome
TI  - Alemtuzumab in refractory Sézary syndrome.
TY  - research article
VL  - 91
ER  -